US and UK Medtech Groups Call for Zero-for-Zero Tariffs
AdvaMed and ABHI are calling for zero-for-zero tariffs and greater regulatory alignment between the US and UK to protect patient access and medtech innovation.
AdvaMed and ABHI are calling for zero-for-zero tariffs and greater regulatory alignment between the US and UK to protect patient access and medtech innovation.
AdvaMed and ABHI are calling for zero-for-zero tariffs and greater regulatory alignment between the US and UK to protect patient access and medtech innovation.